HCC can express tumor associated antigens ((like NY-Eso-1, glypican-3, alpha-feto protein, Mage-3), and T cells specific for these tumor-associated antigens are present in HBV-related HCC patients [18], and they correlate with slower disease progression [19]. The gene discussed is GPC3; the disease is hepatocellular carcinoma.